Work

Supplementary Figure S2 from A MERTK-Targeting Antibody–Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer Cells

Year: 2026

Type: supplementary-materials

Abstract: This figure shows the affinity and specificity of RGX-019 binding and MERTK degradation

DOI: 10.1158/0008-5472.32714416

Authors: Shugaku Takeda, Subhasree Sridhar, Daniel Schefer, Celia Andreu-Agullo, Pui C. Lo, Minhee Lee, Robert Busby, David M. Darst, Anne Assmus, Suresh Anaganti, Nils Halberg, Benjamin N. Ostendorf, Ivo C. Lorenz, Sohail F. Tavazoie, Masoud F. Tavazoie, Isabel Kurth

Language: English

Topic: Immune cells in cancer

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165030724

Cites:

Cited by:

Related to: 10